Penetration-enhanced Direct DBD Non-thermal Plasma for Hair Loss
NCT ID: NCT06149221
Last Updated: 2024-04-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
19 participants
INTERVENTIONAL
2023-09-01
2024-04-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cold Plasma to Treat Hair Loss
NCT04379752
Efficacy and Safety of Platelet Rich Plasma in Androgenetic Alopecia
NCT02074943
Enhancing Hair Density With Platelet Rich Fibrin Matrix (PRFM)
NCT01590238
A Novel Approach to Treating Androgenetic Alopecia in Females With Low Level Laser Therapy
NCT01967277
Treatment of Androgenetic Alopecia in Males and Females
NCT01437163
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
NTAP treatment
Treatment arm subjects receive the trial intervention
NTAP
Cold plasma is generated and applied to the scalp area, which was previously soaked with normal saline
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
NTAP
Cold plasma is generated and applied to the scalp area, which was previously soaked with normal saline
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ability to keep in-person follow-up appointments
Exclusion Criteria
* starting or discontinuing any hair loss treatments within 6 months of start date
* allergy to any components of the carrier solution
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dr. Peter C. Friedman
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Peter C. Friedman
President
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Skin Center Dermatology Group
New City, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DCAP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.